<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="multimodal analgesic therapies, including migraine therapies, regional anesthesia, subdissociative-dose ketamine," exact="nitrous oxide," post="intravenous lidocaine and gabapentinoids, as well as broad programmatic"/>
 <result pre="including migraine therapies, regional anesthesia, subdissociative-dose ketamine, nitrous oxide, intravenous" exact="lidocaine" post="and gabapentinoids, as well as broad programmatic initiatives promoting"/>
 <result pre="analgesics and nonpharmacologic interventions. Results While migraine therapies, regional anesthesia," exact="nitrous oxide" post="and subdissociative-dose ketamine are supported by a relatively robust"/>
 <result pre="Results While migraine therapies, regional anesthesia, nitrous oxide and subdissociative-dose" exact="ketamine" post="are supported by a relatively robust evidence base, data"/>
 <result pre="was the single most commonly administered analgesic (20%), followed by" exact="ibuprofen" post="(17%; Table 2). Despite rather small reductions in pain"/>
 <result pre="and giving primacy to non-opioid interventions of known efficacy (i.e.," exact="dopamine" post="agonists, serotonin agonists) has been remarkably slow [ 25]."/>
 <result pre="with permission from Morrison et al. [ 37] Intravenous subdissociative-dose" exact="ketamine" post="has also been the subject of a number of"/>
 <result pre="subject of a number of recent ED studies. Perhaps because" exact="ketamine" post="has long been used for procedural sedation and as"/>
 <result pre="and as an induction agent for rapid sequence intubation, subdissociative-dose" exact="ketamine" post="(0.1–0.4 mg/kg) as monotherapy or adjunctive therapy has become"/>
 <result pre="position paper from the American Academy of Emergency Medicine, subdissociative-dose" exact="ketamine" post="was judged safe and effective both as a single"/>
 <result pre="opioids for the treatment of acute pain [ 38]. Although" exact="ketamine" post="is well known to cause troubling neuropsychiatric adverse effects"/>
 <result pre="to be minor and short-lived. Eight supportive studies of subdissociative-dose" exact="ketamine" post="pertinent to pre-hospital and ED settings have been published"/>
 <result pre="Another recent study examined adverse effects and analgesic efficacy of" exact="ketamine" post="administered as either a single intravenous push (IVP) or"/>
 <result pre="analgesic efficacy with fewer reports of adverse effects for when" exact="ketamine" post="was infused over a 15-min infusion period. While subdissociative-dose"/>
 <result pre="physicians should inform patients about potential side effects and avoid" exact="ketamine" post="for patients with underlying psychiatric disorders or substance abuse-induced"/>
 <result pre="and analgesic among pediatric ED patients. Administered as a 50%–70%" exact="nitrous oxide" post="vapor, it is used for children undergoing a number"/>
 <result pre="ED patients. In a recent non-controlled pilot study of self-administered" exact="nitrous oxide" post="among 85 ED patients with abscesses or orthopedic injuries,"/>
 <result pre="oxide among 85 ED patients with abscesses or orthopedic injuries," exact="nitrous oxide" post="appeared to be safe and well tolerated. Given the"/>
 <result pre="decreasing opioid use in the ED, it is likely that" exact="nitrous oxide" post="use will increase over time [ 49]. In contrast"/>
 <result pre="have recently been promoted for ED use [ 50]. Intravenous" exact="lidocaine" post="has demonstrated efficacy for central pain syndromes and neuropathic"/>
 <result pre="setting. Two Iranian research groups recently published studies of intravenous" exact="lidocaine" post="for ED the treatment of renal colic. The first"/>
 <result pre="ED the treatment of renal colic. The first studied intravenous" exact="lidocaine" post="as an adjuvant to opioid therapy in 110 patients"/>
 <result pre="The investigators reported that those treated with a combination of" exact="lidocaine" post="and morphine reported fewer episodes of nausea and more"/>
 <result pre="240 patients with renal colic directly compared monotherapy with intravenous" exact="lidocaine" post="to morphine [ 52]. Pain reduction was reported to"/>
 <result pre="those treated with lidocaine. In another US study comparing intravenous" exact="lidocaine" post="to intravenous ketorolac for ED patients with acute radicular"/>
 <result pre="lidocaine. In another US study comparing intravenous lidocaine to intravenous" exact="ketorolac" post="for ED patients with acute radicular back pain, lidocaine"/>
 <result pre="intravenous ketorolac for ED patients with acute radicular back pain," exact="lidocaine" post="was less impressive, failing to reach a clinically significant"/>
 <result pre="reported pain intensity over 60 min [ 53]. While intravenous" exact="lidocaine" post="has thus far received limited investigation in the ED,"/>
 <result pre="specifically non-steroidal anti-inflammatory agents, ketamine, lidocaine/ropivacaine, benzodiazepines, corticosteroids, gabapentinoids and" exact="nitrous oxide." post="Ultrasound-guided regional anesthesia is advised for appropriate extremity fractures"/>
 <result pre="S et al. Is there a role for intravenous subdissociative-dose" exact="ketamine" post="administered as an adjunct to opioids or as a"/>
 <result pre="The effect of combined treatment with morphine sulphate and low-dose" exact="ketamine" post="in a prehospital setting Scand J Trauma Resusc Emerg"/>
 <result pre="Jennings PA Cameron P Bernard S et al. Morphine and" exact="ketamine" post="is superior to morphine alone for out-of-hospital trauma analgesia:"/>
 <result pre="et al. Management of severe acute pain in emergency settings:" exact="ketamine" post="reduces morphine consumption Am J Emerg Med 2007 25"/>
 <result pre="Herring AA Stone MB Frazee BW Effective analgesia with low-dose" exact="ketamine" post="and reduced dose hydromorphone in ED patients with severe"/>
 <result pre="Frazee BW Effective analgesia with low-dose ketamine and reduced dose" exact="hydromorphone" post="in ED patients with severe pain Am J Emerg"/>
 <result pre="44. Beaudoin FL Lin C Guan W Merchant RC Low-dose" exact="ketamine" post="improves pain relief in patients receiving intravenous opioids for"/>
 <result pre="45. Miller JP Schauer SG Ganem VJ Bebarta VS Low-dose" exact="ketamine" post="vs morphine for acute pain in the ED: a"/>
 <result pre="Motov S Rockoff B Cohen V et al. Intravenous subdissociative-dose" exact="ketamine" post="vs. morphine for analgesia in the emergency department: a"/>
 <result pre="A prospective randomized, double-dummy trial comparing IV push low dose" exact="ketamine" post="to short infusion of low dose ketamine for treatment"/>
 <result pre="push low dose ketamine to short infusion of low dose" exact="ketamine" post="for treatment of pain in the ED Am J"/>
 <result pre="Chudnofsky CR Manur R et al. The use of inhaled" exact="nitrous oxide" post="for analgesia in adult ED patients: a pilot study"/>
 <result pre="A Rashidian Dezfouli H Zamani Kiasari A et al. Does" exact="lidocaine" post="as an adjuvant to morphine improve pain relief in"/>
 <result pre="K Vaezi H Golzari SE et al. Effectiveness of intravenous" exact="lidocaine" post="versus intravenous morphine for patients with renal colic in"/>
 <result pre="53. Tanen DA Shimada M Danish DC et al. Intravenous" exact="lidocaine" post="for the emergency department treatment of acute radicular low"/>
</results>
